Pterostilbene inhibits lung squamous cell carcinoma growth in vitro and in vivo by inducing S phase arrest and apoptosis

doi:10.3892/ol.2019.10499

CNU IR > Pharmacy and Science > Dept. of Pharmacy > Periodical Articles > Item 310902800/32612

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/32612

Title:	Pterostilbene inhibits lung squamous cell carcinoma growth in vitro and in vivo by inducing S phase arrest and apoptosis
Authors:	Tan, Kok-Tong Chen, Ping-Wen Li, Shiming Ke, Te-Min Lin, Sheng-Hao Ching-Chieh Yang(楊清傑)
Contributors:	Tungs Taichung Metro Harbor Hosp, Dept Surg Natl Chung Hsing Univ, Inst Biomed Sci Huanggang Normal Univ, Hubei Key Lab Econ Forest Germplasm Improvement & Chi Mei Med Ctr, Dept Radiat Oncol Changhua Christian Hosp, Div Chest Med, Dept Internal Med Natl Sun Yat Sen Univ, Inst Biomed Sci Chia Nan Univ Pharm & Sci, Dept Pharm
Keywords:	lung squamous cell carcinoma pterostilbene cell cycle apoptosis
Date:	2019-08
Issue Date:	2020-07-29 13:52:05 (UTC+8)
Publisher:	SPANDIDOS PUBL LTD
Abstract:	Natural dietary components have become the subject of an increasing amount of interest due to the side effects of anticancer treatment. Pterostilbene, an analog of resveratrol, is primarily found in grapes, and has been suggested to exert antioxidant and anticancer effects in different tumor types. The present study aimed to investigate the antitumor effects and molecular mechanisms of pterostilbene in the human lung squamous cell carcinoma (SqCC) cell line, H520. The results of the present study indicate that pterostilbene significantly reduced cell viability and induced S phase arrest, and that treatment with pterostilbene was associated with the downregulation of cyclin A and cyclin E, as with the upregulation of p21 and p27 expression in H520 cells. In the apoptosis analysis, pterostilbene induced S phase accumulation and the activation of caspase-3, -8 and -9 in H520 cells, potentially through the activation of extrinsic and intrinsic apoptotic pathways. Additionally, the in vivo study demonstrated that pterostilbene effectively inhibited lung SqCC growth in a H520 xenograft model. Given the in vitro and in vivo antitumor effects of pterostilbene demonstrated in the present study, pterostilbene may serve a novel and effective therapeutic agent to for patients with SqCC.
Relation:	Oncology Letters, v.18, n.2, pp.1631-1640
Appears in Collections:	[Dept. of Pharmacy] Periodical Articles

Files in This Item:

File	Description	Size	Format
10.3892-ol.2019.10499.pdf		1265Kb	Adobe PDF	261	View/Open
index.html		0Kb	HTML	911	View/Open

Loading...